Novel Triaryl Sulfonamide Derivatives as Selective Cannabinoid Receptor 2 Inverse Agonist and Osteoclast Inhibitor: Discovery, Optimization and Biological Evaluation

Ítems similars

• Trisubstituted Sulfonamides: A New Chemotype for Development of Potent and Selective CB(2) Receptor Inverse Agonists
  per: Ouyang, Qin, et al.
  Publicat: (2013)
• Lead Discovery, Chemistry Optimization, and Biological Evaluation Studies of Novel Biamide Derivatives as CB(2) Receptor Inverse Agonists and Osteoclast Inhibitors
  per: Yang, Peng, et al.
  Publicat: (2012)
• Examining the critical roles of human CB2 receptor residues Valine 3.32 (113) and Leucine 5.41 (192) in ligand recognition and downstream signaling activities
  per: Alqarni, Mohammed, et al.
  Publicat: (2014)
• Molecular Fingerprint-based Artificial Neural Networks QSAR for Ligand Biological Activity Predictions
  per: Myint, Kyaw-Zeyar, et al.
  Publicat: (2012)
• LiCABEDS II. Modeling of Ligand Selectivity for G-protein Coupled Cannabinoid Receptors
  per: Ma, Chao, et al.
  Publicat: (2013)